Back to Browse Journals » Neuropsychiatric Disease and Treatment » Volume 10

Neuropsychiatric Disease and Treatment


Archive: Volume 10, 2014

Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo

Yanik ME, Erfan G, Albayrak Y, Aydin M, Kulac M, Kuloglu M

Neuropsychiatric Disease and Treatment 2014, 10:2361-2367

Published Date: 12 December 2014

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia

Fujiki R, Morita K, Sato M, Yamashita Y, Kato Y, Ishii Y, Shoji Y, Uchimura N

Neuropsychiatric Disease and Treatment 2014, 10:2353-2360

Published Date: 11 December 2014

Parkinson’s disease-associated melanin steal

Hinz M, Stein A, Cole T

Neuropsychiatric Disease and Treatment 2014, 10:2331-2337

Published Date: 10 December 2014

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia

Karthikeyan R, Marimuthu G, Ramasubramanian C, Arunachal G, BaHammam AS, Spence DW, Cardinali DP, Brown GM, Pandi-Perumal SR

Neuropsychiatric Disease and Treatment 2014, 10:2325-2330

Published Date: 9 December 2014

Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study

Nishimura J, Kakeda S, Abe O, Yoshimura R, Watanabe K, Goto N, Hori H, Sato T, Takao H, Kabasawa H, Nakamura J, Korogi Y

Neuropsychiatric Disease and Treatment 2014, 10:2315-2323

Published Date: 8 December 2014

Remediation of context-processing deficits in schizophrenia: preliminary data with ambiguous sentences

Besche-Richard C, Terrien S, Lesgourgues M, Béchiri-Payet C, Gierski F, Limosin F

Neuropsychiatric Disease and Treatment 2014, 10:2307-2312

Published Date: 3 December 2014

Possible association between phantom vibration syndrome and occupational burnout

Chen CP, Wu CC, Chang LR, Lin YH

Neuropsychiatric Disease and Treatment 2014, 10:2307-2314

Published Date: 4 December 2014

Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke

Amiri-Nikpour MR, Nazarbaghi S, Ahmadi-Salmasi B, Mokari T, Tahamtan U, Rezaei Y

Neuropsychiatric Disease and Treatment 2014, 10:2299-2306

Published Date: 3 December 2014

The clinical psychologist and the management of inpatient pain: a small case series

Childs SR, Casely EM, Kuehler BM, Ward S, Halmshaw CL, Thomas SE, Goodall ID, Bantel C

Neuropsychiatric Disease and Treatment 2014, 10:2291-2297

Published Date: 2 December 2014

Increasing dependency of older people in nursing homes is associated with need for dental treatments

Zenthöfer A, Rammelsberg P, Cabrera T, Hassel AJ

Neuropsychiatric Disease and Treatment 2014, 10:2285-2290

Published Date: 2 December 2014

Posttraumatic stress symptoms, dissociation, and alexithymia in an Italian sample of flood victims

Craparo G, Gori A, Mazzola E, Petruccelli I, Pellerone M, Rotondo G

Neuropsychiatric Disease and Treatment 2014, 10:2281-2284

Published Date: 28 November 2014

Cluster headache as a first manifestation of multiple sclerosis: case report and literature review

Mijajlović MD, Aleksić VM, Čovičković Šternić NM

Neuropsychiatric Disease and Treatment 2014, 10:2269-2274

Published Date: 25 November 2014

Rehabilitation for a child with recalcitrant anti-N-methyl-D-aspartate receptor encephalitis: case report and literature review

Guo YH, Kuan TS, Hsieh PC, Lien WC, Chang CK, Lin YC

Neuropsychiatric Disease and Treatment 2014, 10:2263-2267

Published Date: 24 November 2014

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions

Koppel J, Greenwald BS

Neuropsychiatric Disease and Treatment 2014, 10:2253-2262

Published Date: 24 November 2014

Foix-Chavany-Marie syndrome in a 17-year-old female with congenital cytomegalovirus infection

Conforti R, Capasso R, Capaldo G, Dato C, Saracino D, Di Iorio G, Melone MA

Neuropsychiatric Disease and Treatment 2014, 10:2249-2252

Published Date: 20 November 2014

Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation

Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, Worster A, Varenbut M, Daiter J, Marsh DC, Desai D, Thabane L, Samaan Z

Neuropsychiatric Disease and Treatment 2014, 10:2239-2247

Published Date: 19 November 2014

A comparative study of 43 patients with mirror-like intracranial aneurysms: risk factors, treatment, and prognosis

Wang R, Zhang D, Zhao JZ, Wang S, Zhao YL, Niu HC

Neuropsychiatric Disease and Treatment 2014, 10:2231-2237

Published Date: 19 November 2014

Bereavement and behavioral changes as risk factors for cognitive decline in adults with Down syndrome

Fonseca LM, Oliveira MC, Guilhoto LM, Cavalheiro EA, Bottino CM

Neuropsychiatric Disease and Treatment 2014, 10:2209-2219

Published Date: 17 November 2014

Comparison of three screening tests for autism in preterm children with birth weights less than 1,500 grams

Dudova I, Markova D, Kasparova M, Zemankova J, Beranova S, Urbanek T, Hrdlicka M

Neuropsychiatric Disease and Treatment 2014, 10:2201-2208

Published Date: 17 November 2014

Below and beyond the recognition of emotional facial expressions in alcohol dependence: from basic perception to social cognition

D’Hondt F, Campanella S, Kornreich C, Philippot P, Maurage P

Neuropsychiatric Disease and Treatment 2014, 10:2177-2182

Published Date: 18 November 2014

Posttraumatic epilepsy: current and emerging treatment options

Paiva WS, Mello LE

Neuropsychiatric Disease and Treatment 2014, 10:2159-2161

Published Date: 13 November 2014

Decreased serum level of NGF in alcohol-dependent patients with declined executive function

Bae H, Ra Y, Han C, Kim DJ

Neuropsychiatric Disease and Treatment 2014, 10:2153-2157

Published Date: 13 November 2014

Severe agitation in severe early-onset Alzheimer’s disease resolves with ECT

Aksay SS, Hausner L, Frölich L, Sartorius A

Neuropsychiatric Disease and Treatment 2014, 10:2147-2151

Published Date: 13 November 2014

Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis

Alfadhel M, Saleh N, Alenazi H, Baffoe-Bonnie H

Neuropsychiatric Disease and Treatment 2014, 10:2135-2137

Published Date: 12 November 2014

Association of BDNF Val66Met polymorphism with HPA and SAM axis reactivity to psychological and physical stress

Tsuru J, Tanaka Y, Ishitobi Y, Maruyama Y, Inoue A, Kawano A, Ikeda R, Ando T, Oshita H, Aizawa S, Masuda K, Higuma H, Kanehisa M, Ninomiya T, Akiyoshi J

Neuropsychiatric Disease and Treatment 2014, 10:2123-2133

Published Date: 11 November 2014

A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome

Harada T, Inada K, Yamada K, Sakamoto K, Ishigooka J

Neuropsychiatric Disease and Treatment 2014, 10:2115-2121

Published Date: 10 November 2014

Age-associated decrease in global DNA methylation in patients with major depression

Tseng PT, Lin PY, Lee Y, Hung CF, Lung FW, Chen CS, Chong MY

Neuropsychiatric Disease and Treatment 2014, 10:2105-2114

Published Date: 10 November 2014

Psychiatric comorbidities in patients with major depressive disorder

Thaipisuttikul P, Ittasakul P, Waleeprakhon P, Wisajun P, Jullagate S

Neuropsychiatric Disease and Treatment 2014, 10:2097-2103

Published Date: 10 November 2014

Iron deficiency and cognitive functions

Jáuregui-Lobera I

Neuropsychiatric Disease and Treatment 2014, 10:2087-2095

Published Date: 10 November 2014

Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?

Celik Guzel E, Bakkal E, Guzel S, Eroglu HE, Acar A, Kuçukyalcin V, Topcu B

Neuropsychiatric Disease and Treatment 2014, 10:2079-2086

Published Date: 5 November 2014

Social cognition and its relationship to functional outcomes in patients with sustained acquired brain injury

Ubukata S, Tanemura R, Yoshizumi M, Sugihara G, Murai T, Ueda K

Neuropsychiatric Disease and Treatment 2014, 10:2061-2068

Published Date: 3 November 2014

Spinal cord demyelination combined with hyperhomocysteinemia: a case report

Hao MM, Zhang Y, Hou SX, Chen YL, Shi M, Zhao G, Deng YC

Neuropsychiatric Disease and Treatment 2014, 10:2057-2059

Published Date: 3 November 2014

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report

Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM

Neuropsychiatric Disease and Treatment 2014, 10:2049-2055

Published Date: 31 October 2014

Factors associated with adherence to medication among depressed patients from Saudi Arabia: a cross-sectional study

Al Jumah K, Hassali MA, Al Qhatani D, El Tahir K

Neuropsychiatric Disease and Treatment 2014, 10:2031-2037

Published Date: 28 October 2014

Parental bonding and attitudes toward suicide among medical college students in Japan

Hashimoto K, Sugawara N, Tanaka O, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2014, 10:2015-2020

Published Date: 23 October 2014

Elongation of pulse width as an augmentation strategy in electroconvulsive therapy

Kawashima H, Suwa T, Murai T, Yoshioka R

Neuropsychiatric Disease and Treatment 2014, 10:2009-2014

Published Date: 23 October 2014

Nothing to smile about

Luca M, Luca A, Grasso CMAV, Calandra C

Neuropsychiatric Disease and Treatment 2014, 10:1999-2008

Published Date: 23 October 2014

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease [Corrigendum]

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM

Neuropsychiatric Disease and Treatment 2014, 10:1997-1998

Published Date: 20 October 2014

Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry

Hashimoto N, Nakaaki S, Kawaguchi A, Sato J, Kasai H, Nakamae T, Narumoto J, Miyata J, Furukawa TA, Mimura M

Neuropsychiatric Disease and Treatment 2014, 10:1987-1996

Published Date: 20 October 2014

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia

Kikuchi YS, Sato W, Ataka K, Yagisawa K, Omori Y, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2014, 10:1973-1978

Published Date: 15 October 2014

Cortisol levels and sleep patterns in infants with orofacial clefts undergoing surgery

Mueller AA, Kalak N, Schwenzer-Zimmerer K, Holsboer-Trachsler E, Brand S

Neuropsychiatric Disease and Treatment 2014, 10:1965-1972

Published Date: 15 October 2014

Neuropsychiatric symptoms and celiac disease

Urban-Kowalczyk M, Śmigielski J, Gmitrowicz A

Neuropsychiatric Disease and Treatment 2014, 10:1961-1964

Published Date: 14 October 2014

Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics

Adam UU, Husain N, Haddad PM, Munshi T, Tariq F, Naeem F, Chaudhry IB

Neuropsychiatric Disease and Treatment 2014, 10:1953-1959

Published Date: 14 October 2014

Alexithymia in parents and adolescent anorexic daughters: comparing the responses to TSIA and TAS-20 scales

Balottin L, Nacinovich R, Bomba M, Mannarini S

Neuropsychiatric Disease and Treatment 2014, 10:1941-1951

Published Date: 9 October 2014

Violent victimization of adult patients with severe mental illness: a systematic review

Latalova K, Kamaradova D, Prasko J

Neuropsychiatric Disease and Treatment 2014, 10:1925-1939

Published Date: 9 October 2014

EMSAM (deprenyl patch): how a promising antidepressant was underutilized

Asnis GM, Henderson MA

Neuropsychiatric Disease and Treatment 2014, 10:1911-1923

Published Date: 6 October 2014

Diagnosing pseudobulbar affect in traumatic brain injury

Engelman W, Hammond FM, Malec JF

Neuropsychiatric Disease and Treatment 2014, 10:1903-1910

Published Date: 7 October 2014

Anxiety and depression levels in prepubertal obese children: a case-control study

Esposito M, Gallai B, Roccella M, Marotta R, Lavano F, Lavano SM, Mazzotta G, Bove D, Sorrentino M, Precenzano F, Carotenuto M

Neuropsychiatric Disease and Treatment 2014, 10:1897-1902

Published Date: 3 October 2014

Prevalence of stress in junior doctors during their internship training: a cross-sectional study of three Saudi medical colleges’ hospitals

Abdulghani HM, Irshad M, Al Zunitan MA, Al Sulihem AA, Al Dehaim MA, Al Esefir WA, Al Rabiah AM, Kameshki RN, Alrowais NA, Sebiany A, Haque S

Neuropsychiatric Disease and Treatment 2014, 10:1879-1886

Published Date: 25 September 2014

Towards a framework for treatment effectiveness in schizophrenia

Juckel G, de Bartolomeis A, Gorwood P, Mosolov S, Pani L, Rossi A, Sanjuan J

Neuropsychiatric Disease and Treatment 2014, 10:1867-1878

Published Date: 24 September 2014

Early prediction of blonanserin response in Japanese patients with schizophrenia

Kishi T, Matsuda Y, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2014, 10:1861-1866

Published Date: 23 September 2014

Development and validation of the Pictorial Cognitive Screening Inventory for illiterate people with dementia

Park S, Park SE, Kim MJ, Jung HY, Choi JS, Park KH, Kim I, Lee JY

Neuropsychiatric Disease and Treatment 2014, 10:1837-1845

Published Date: 23 September 2014

Kynurenine and depressive symptoms in a poststroke population

Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, Snaiderman A, Lanctôt KL

Neuropsychiatric Disease and Treatment 2014, 10:1827-1835

Published Date: 22 September 2014

A multidimensional risk factor model for suicide attempts in later life

Chan SMS, Chiu FKH, Lam CWL, Wong SMC, Conwell Y

Neuropsychiatric Disease and Treatment 2014, 10:1807-1817

Published Date: 18 September 2014

Sleep and cognitive problems in patients with attention-deficit hyperactivity disorder

Lee HK, Jeong JH, Kim NY, Park MH, Kim TW, Seo HJ, Lim HK, Hong SC, Han JH

Neuropsychiatric Disease and Treatment 2014, 10:1799-1805

Published Date: 17 September 2014

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2014, 10:1793-1798

Published Date: 18 September 2014

Attention-deficit/hyperactivity disorder in postsecondary students

Nugent K, Smart W

Neuropsychiatric Disease and Treatment 2014, 10:1781-1791

Published Date: 26 September 2014

Modulation of the GABAergic pathway for the treatment of fragile X syndrome

Lozano R, Hare EB, Hagerman RJ

Neuropsychiatric Disease and Treatment 2014, 10:1769-1779

Published Date: 16 September 2014

Reversible brain atrophy and cognitive impairment in an adolescent Japanese patient with primary adrenal Cushing’s syndrome

Ohara N, Suzuki H, Suzuki A, Kaneko M, Ishizawa M, Furukawa K, Abe T, Matsubayashi Y, Yamada T, Hanyu O, Shimohata T, Sone H

Neuropsychiatric Disease and Treatment 2014, 10:1763-1767

Published Date: 15 September 2014

No change in N-acetyl aspartate in first episode of moderate depression after antidepressant treatment: 1H magnetic spectroscopy study of left amygdala and left dorsolateral prefrontal cortex

Bajs Janović M, Kalember P, Janović Š, Hrabač P, Folnegović Grošić P, Grošić V, Radoš M, Henigsberg N

Neuropsychiatric Disease and Treatment 2014, 10:1753-1762

Published Date: 17 September 2014

Cognitive assessments for the early diagnosis of dementia after stroke

Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S

Neuropsychiatric Disease and Treatment 2014, 10:1743-1751

Published Date: 12 September 2014

Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions

Okamoto H, Iyo M, Ueda K, Han C, Hirasaki Y, Namiki T

Neuropsychiatric Disease and Treatment 2014, 10:1727-1742

Published Date: 12 September 2014

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study

Ishioka M, Sugawara N, Kaneda A, Okubo N, Iwane K, Takahashi I, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2014, 10:1721-1725

Published Date: 11 September 2014

Association between smoking and cognitive impairment in multiple sclerosis

Özcan ME, İnce B, Bingöl A, Ertürk S, Altınöz MA, Karadeli HH, Koçer A, Asil T

Neuropsychiatric Disease and Treatment 2014, 10:1715-1719

Published Date: 10 September 2014

Validity and clinical utilization of the Chinese version of the Gotland Male Depression Scale at a men’s health polyclinic

Chu CL, Chen Y, Jiang KH, Chen JL, Lee CP, Chau YL, Chen CY

Neuropsychiatric Disease and Treatment 2014, 10:1707-1714

Published Date: 10 September 2014

Animal models of epilepsy: use and limitations

Kandratavicius L, Balista PA, Lopes-Aguiar C, Ruggiero RN, Umeoka EH, Garcia-Cairasco N, Bueno-Junior LS, Leite JP

Neuropsychiatric Disease and Treatment 2014, 10:1693-1705

Published Date: 9 September 2014

Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment

Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S, Mohamad K

Neuropsychiatric Disease and Treatment 2014, 10:1677-1691

Published Date: 9 September 2014

Vitamin B12, folate, and homocysteine levels in patients with obsessive–compulsive disorder

Türksoy N, Bilici R, Yalçıner A, Özdemir YÖ, Örnek I, Tufan AE, Kara A

Neuropsychiatric Disease and Treatment 2014, 10:1671-1675

Published Date: 9 September 2014

Decreased mean platelet volume in panic disorder

Göğçegöz Gül I, Eryılmaz G, Özten E, Hızlı Sayar G

Neuropsychiatric Disease and Treatment 2014, 10:1665-1669

Published Date: 4 September 2014

Risk of epilepsy in patients with systemic lupus erythematosus – a retrospective cohort study

Tsai JD, Lin CL, Lin CC, Sung FC, Lue KH

Neuropsychiatric Disease and Treatment 2014, 10:1635-1643

Published Date: 2 September 2014

Yokukansan and its ingredients as possible treatment options for schizophrenia

Yu CH, Ishii R, Yu SC, Takeda M

Neuropsychiatric Disease and Treatment 2014, 10:1629-1634

Published Date: 1 September 2014

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan

Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K

Neuropsychiatric Disease and Treatment 2014, 10:1621-1627

Published Date: 30 August 2014

Aggression, impulsivity, and suicide risk in benign chronic pain patients – a cross-sectional study

Margari F, Lorusso M, Matera E, Pastore A, Zagaria G, Bruno F, Puntillo F, Margari L

Neuropsychiatric Disease and Treatment 2014, 10:1613-1620

Published Date: 2 September 2014

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU

Neuropsychiatric Disease and Treatment 2014, 10:1605-1611

Published Date: 30 August 2014

Motivation for treatment in patients with substance use disorder: personal volunteering versus legal/familial enforcement

Bilici R, Yazici E, Tufan AE, Mutlu E, İzci F, Ugurlu GK

Neuropsychiatric Disease and Treatment 2014, 10:1599-1604

Published Date: 30 August 2014

Hepatotoxicity induced by clozapine: a case report and review of literature

Wu Chou AI, Lu ML, Shen WW

Neuropsychiatric Disease and Treatment 2014, 10:1585-1587

Published Date: 26 August 2014

Influence of patient characteristics on care time in patients hospitalized with schizophrenia

Sugibayashi Y, Yoshimura K, Yamauchi K, Inagaki A, Ikegami N

Neuropsychiatric Disease and Treatment 2014, 10:1577-1584

Published Date: 25 August 2014

Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure

Spanemberg L, Caldieraro MA, Vares EA, Wollenhaupt-Aguiar B, Kauer-Sant’Anna M, Kawamoto SY, Galvão E, Parker G, Fleck MP

Neuropsychiatric Disease and Treatment 2014, 10:1523-1531

Published Date: 19 August 2014

Diagnostic and therapeutic utility of neuroimaging in depression: an overview

Wise T, Cleare AJ, Herane A, Young AH, Arnone D

Neuropsychiatric Disease and Treatment 2014, 10:1509-1522

Published Date: 19 August 2014

Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study

Samaan Z, Bawor M, Dennis BB, Plater C, Varenbut M, Daiter J, Worster A, Marsh DC, Tan C, Desai D, Thabane L, Pare G

Neuropsychiatric Disease and Treatment 2014, 10:1503-1508

Published Date: 19 August 2014

Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version

Waleeprakhon P, Ittasakul P, Lotrakul M, Wisajun P, Jullagate S, Ketter TA

Neuropsychiatric Disease and Treatment 2014, 10:1497-1502

Published Date: 18 August 2014

A retrospective analysis focusing on a group of patients with dual diagnosis treated by both mental health and substance use services

Di Lorenzo R, Galliani A, Guicciardi A, Landi G, Ferri P

Neuropsychiatric Disease and Treatment 2014, 10:1479-1488

Published Date: 11 August 2014

Post-traumatic epilepsy: current and emerging treatment options

Szaflarski JP, Nazzal Y, Dreer LE

Neuropsychiatric Disease and Treatment 2014, 10:1469-1477

Published Date: 11 August 2014

High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke

Kara H, Akinci M, Degirmenci S, Bayir A, Ak A, Nayman A, Unlu A, Akyurek F, Sivri M

Neuropsychiatric Disease and Treatment 2014, 10:1451-1457

Published Date: 6 August 2014

Examining the relationship between adherence and satisfaction with antidepressant treatment

Aljumah K, Ahmad Hassali A, AlQhatani S

Neuropsychiatric Disease and Treatment 2014, 10:1433-1438

Published Date: 4 August 2014

Sleep quality changes in insomniacs and non-insomniacs after acute altitude exposure and its relationship with acute mountain sickness

Tang XG, Zhang JH, Gao XB, Li QN, Li JB, Yu J, Qin J, Huang L

Neuropsychiatric Disease and Treatment 2014, 10:1423-1432

Published Date: 31 July 2014

The relationship between insight and subjective experience in schizophrenia

Kako Y, Ito K, Hashimoto N, Toyoshima K, Shimizu Y, Mitsui N, Fujii Y, Tanaka T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:1415-1422

Published Date: 29 July 2014

Caregiver burden and coping strategies in caregivers of patients with Alzheimer’s disease

Iavarone A, Ziello AR, Pastore F, Fasanaro AM, Poderico C

Neuropsychiatric Disease and Treatment 2014, 10:1407-1413

Published Date: 29 July 2014

Perspectives on perceived stigma and self-stigma in adult male patients with depression

Latalova K, Kamaradova D, Prasko J

Neuropsychiatric Disease and Treatment 2014, 10:1399-1405

Published Date: 29 July 2014

Cognitive dysfunction in pediatric multiple sclerosis

Suppiej A, Cainelli E

Neuropsychiatric Disease and Treatment 2014, 10:1385-1392

Published Date: 23 July 2014

Reduced brain resting-state network specificity in infants compared with adults

Wylie KP, Rojas DC, Ross RG, Hunter SK, Maharajh K, Cornier M-A, Tregellas JR

Neuropsychiatric Disease and Treatment 2014, 10:1349-1359

Published Date: 21 July 2014

A cross-sectional study on perception of stigma by Chinese schizophrenia patients [Expression of concern]

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:1333-1334

Published Date: 18 July 2014

Dimensional assessment of DSM-5 social anxiety symptoms among university students and its relationship with functional impairment

Dell’Osso L, Abelli M, Pini S, Carlini M, Carpita B, Macchi E, Gorrasi F, Mengali F, Tognetti R, Massimetti G

Neuropsychiatric Disease and Treatment 2014, 10:1325-1332

Published Date: 16 July 2014

Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study

Zhu W, Zhang Z, Qi J, Liu F, Chen J, Zhao J, Guo X

Neuropsychiatric Disease and Treatment 2014, 10:1317-1323

Published Date: 14 July 2014

Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia

Vlcek P, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:1309-1315

Published Date: 14 July 2014

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H

Neuropsychiatric Disease and Treatment 2014, 10:1287-1296

Published Date: 10 July 2014

Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer’s disease

Pereira ML, Camargo MVZA, Aprahamian I, Forlenza OV

Neuropsychiatric Disease and Treatment 2014, 10:1273-1285

Published Date: 9 July 2014

Cerebral palsy in Al-Quseir City, Egypt: prevalence, subtypes, and risk factors

El-Tallawy HN, Farghaly WMA, Shehata GA, Rageh TA, Metwally NA, Badry R, Sayed MAM, Abd El Hamed M, Abd-Elwarth A, Kandil MR

Neuropsychiatric Disease and Treatment 2014, 10:1267-1272

Published Date: 8 July 2014

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study

Grošić V, Folnegović Grošić P, Kalember P, Bajs Janović M, Radoš M, Mihanović M, Henigsberg N

Neuropsychiatric Disease and Treatment 2014, 10:1243-1253

Published Date: 7 July 2014

Investigation of health anxiety and its related factors in nursing students

Zhang Y, Zhao Y, Mao S, Li G, Yuan Y

Neuropsychiatric Disease and Treatment 2014, 10:1223-1234

Published Date: 7 July 2014

Quantification of functional abilities in Rett syndrome: a comparison between stages III and IV

Monteiro CBM, Savelsbergh GJP, Smorenburg ARP, Graciani Z, Torriani-Pasin C, de Abreu LC, Valenti VE, Kok F

Neuropsychiatric Disease and Treatment 2014, 10:1213-1222

Published Date: 3 July 2014

Sleep duration and subjective psychological well-being in adolescence: a longitudinal study in Switzerland and Norway

Kalak N, Lemola S, Brand S, Holsboer–Trachsler E, Grob A

Neuropsychiatric Disease and Treatment 2014, 10:1199-1207

Published Date: 3 July 2014

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression

Dannehl K, Rief W, Schwarz MJ, Hennings A, Riemer S, Selberdinger V, Stapf T, Euteneuer F

Neuropsychiatric Disease and Treatment 2014, 10:1191-1197

Published Date: 28 June 2014

COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study

Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J

Neuropsychiatric Disease and Treatment 2014, 10:1183-1190

Published Date: 25 June 2014

Brain meningioma with initial manifestation similar to cervical radiculopathy: a case report

Huang YH, Hong CZ, Wu WT, Li KT, Chou LW

Neuropsychiatric Disease and Treatment 2014, 10:1175-1181

Published Date: 25 June 2014

Improvement of verbal fluency in patients with diffuse brain injury over time

Zaninotto AL, Guirado VM, Baldivia B, Núñez MD, Amorim RL, Teixeira MJ, Lucia MC, Andrade AF, Paiva WS

Neuropsychiatric Disease and Treatment 2014, 10:1155-1160

Published Date: 24 June 2014

A failure to confirm the effectiveness of a brief group psychoeducational program for mothers of children with high-functioning pervasive developmental disorders: a randomized controlled pilot trial

Suzuki M, Yamada A, Watanabe N, Akechi T, Katsuki F, Nishiyama T, Imaeda M, Miyachi T, Otaki K, Mitsuda Y, Ota A, Furukawa TA

Neuropsychiatric Disease and Treatment 2014, 10:1141-1153

Published Date: 30 June 2014

Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis

Pan YQ, Yao J, Wang BJ

Neuropsychiatric Disease and Treatment 2014, 10:1133-1139

Published Date: 20 June 2014

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H

Neuropsychiatric Disease and Treatment 2014, 10:1125-1131

Published Date: 20 June 2014

Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients

Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T

Neuropsychiatric Disease and Treatment 2014, 10:1113-1124

Published Date: 18 June 2014

Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders

Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di Giannantonio M, Thomas A

Neuropsychiatric Disease and Treatment 2014, 10:1093-1101

Published Date: 17 June 2014

Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms

Lozano R, Marín R, Freire I, Santacruz MJ, Pascual-García A

Neuropsychiatric Disease and Treatment 2014, 10:1079-1080

Published Date: 12 June 2014

Tackling nonadherence in psychiatric disorders: current opinion

Farooq S, Naeem F

Neuropsychiatric Disease and Treatment 2014, 10:1069-1077

Published Date: 12 June 2014

Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey

van der Feltz-Cornelis CM, van Os J, Knappe S, Schumann G, Vieta E, Wittchen HU, Lewis SW, Elfeddali I, Wahlbeck K, Linszen D, Obradors-Tarragó C, Haro JM

Neuropsychiatric Disease and Treatment 2014, 10:1057-1068

Published Date: 27 June 2014

Neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials

Petit G, Cimochowska A, Kornreich C, Hanak C, Verbanck P, Campanella S

Neuropsychiatric Disease and Treatment 2014, 10:1025-1037

Published Date: 9 June 2014

Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms

Park CM, Seo HJ, Jung YE, Kim MD, Hong SC, Bahk WM, Yoon BH, Hur MH, Song JM

Neuropsychiatric Disease and Treatment 2014, 10:1017-1023

Published Date: 9 June 2014

Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy

Moretti DV, Binetti G, Zanetti O, Frisoni GB

Neuropsychiatric Disease and Treatment 2014, 10:1003-1009

Published Date: 5 June 2014

Perceiving “ghost” images: a unique case of visual allesthesia with hemianopsia in mitochondrial disease

Murakami H, Ichikawa H, Sugimoto A, Futamura A, Shimizu Y, Sugie M, Miller MW, Kawamura M

Neuropsychiatric Disease and Treatment 2014, 10:999-1002

Published Date: 5 June 2014

Determining a diagnostic cut-off on the Teate Depression Inventory

Balsamo M, Saggino A

Neuropsychiatric Disease and Treatment 2014, 10:987-995

Published Date: 3 June 2014

Effect of calligraphy training on hyperarousal symptoms for childhood survivors of the 2008 China earthquakes

Zhu Z, Wang R, Kao HSR, Zong Y, Liu Z, Tang S, Xu M, Liu ICY, Lam SPW

Neuropsychiatric Disease and Treatment 2014, 10:977-985

Published Date: 3 June 2014

Epileptic and cognitive changes in children with cerebral palsy: an Egyptian study

El-Tallawy HN, Farghaly WMA, Shehata GA, Badry R, Rageh TA

Neuropsychiatric Disease and Treatment 2014, 10:971-975

Published Date: 29 May 2014

Nonepileptic seizures under levetiracetam therapy: a case report of forced normalization process

Anzellotti F, Franciotti R, Zhuzhuni H, D’Amico A, Thomas A, Onofrj M

Neuropsychiatric Disease and Treatment 2014, 10:959-964

Published Date: 23 May 2014

Possible association between vitamin D deficiency and restless legs syndrome

Oran M, Unsal C, Albayrak Y, Tulubas F, Oguz K, Avci O, Turgut N, Alp R, Gurel A

Neuropsychiatric Disease and Treatment 2014, 10:953-958

Published Date: 21 May 2014

Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

Fornaro M, Bandini F, Cestari L, Cordano C, Ogliastro C, Albano C, De Berardis D, Martino M, Escelsior A, Rocchi G, Fornaro P, De Pasquale C

Neuropsychiatric Disease and Treatment 2014, 10:907-914

Published Date: 20 May 2014

Neuropathic sensory symptoms: association with pain and psychological factors

Shaygan M, Böger A, Kröner-Herwig B

Neuropsychiatric Disease and Treatment 2014, 10:897-906

Published Date: 20 May 2014

Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention-deficit/hyperactivity disorder

Coles T, Coon C, DeMuro C, McLeod L, Gnanasakthy A

Neuropsychiatric Disease and Treatment 2014, 10:887-895

Published Date: 19 May 2014

Temperament, character traits, and alexithymia in patients with panic disorder

Izci F, Gültekin BK, Saglam S, Koc MI, Zincir SB, Atmaca M

Neuropsychiatric Disease and Treatment 2014, 10:879-885

Published Date: 16 May 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review

Xue HBH, Liu L, Zhang H, Montgomery W, Treuer T

Neuropsychiatric Disease and Treatment 2014, 10:841-864

Published Date: 16 May 2014

Nerve growth factor variations in patients with mood disorders: no changes in eight weeks of clinical treatment

Liu X, Zhang T, He S, Hong B, Peng D, Su H, Li F, Tang Y, Lin Z, Fang Y, Jiang K

Neuropsychiatric Disease and Treatment 2014, 10:835-840

Published Date: 15 May 2014

Social phobia in Parkinson’s disease: Prevalence and risk factors

Gultekin BK, Ozdilek B, Bestepe EE

Neuropsychiatric Disease and Treatment 2014, 10:829-834

Published Date: 21 May 2014

Latent class analysis on internet and smartphone addiction in college students

Mok JY, Choi SW, Kim DJ, Choi JS, Lee J, Ahn H, Choi EJ, Song WY

Neuropsychiatric Disease and Treatment 2014, 10:817-828

Published Date: 20 May 2014

The association between suicide risk and self-esteem in Japanese university students with major depressive episodes of major depressive disorder

Mitsui N, Asakura S, Shimizu Y, Fujii Y, Toyomaki A, Kako Y, Tanaka T, Kitagawa N, Inoue T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:811-816

Published Date: 15 May 2014

Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry

Paholpak S, Kongsakon R, Pattanakumjorn W, Kanokvut R, Wongsuriyadech W, Srisurapanont M

Neuropsychiatric Disease and Treatment 2014, 10:803-810

Published Date: 15 May 2014

Factors associated with body image distortion in Korean adolescents

Hyun MY, Jung YE, Kim MD, Kwak YS, Hong SC, Bahk WM, Yoon BH, Yoon HW, Yoo B

Neuropsychiatric Disease and Treatment 2014, 10:797-802

Published Date: 13 May 2014

The prevalence of bipolar spectrum disorder in elderly patients with recurrent depression

Lee CI, Jung YE, Kim MD, Hong SC, Bahk WM, Yoon BH

Neuropsychiatric Disease and Treatment 2014, 10:791-795

Published Date: 8 May 2014

Nonergot dopamine-receptor agonists for treating Parkinson's disease – a network meta-analysis

Thorlund K, Wu P, Druyts E, Eapen S, Mills EJ

Neuropsychiatric Disease and Treatment 2014, 10:767-776

Published Date: 7 May 2014

Psychiatry 2050: from younger psychiatrists' perspective

Hassan TM, Habib W, Mazhar MN, Munshi T

Neuropsychiatric Disease and Treatment 2014, 10:723-726

Published Date: 7 May 2014

Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study

Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M

Neuropsychiatric Disease and Treatment 2014, 10:719-722

Published Date: 5 May 2014

Comprehensive cognitive and cerebral hemodynamic evaluation after cranioplasty

Coelho F, Oliveira AM, Paiva WS, Freire FR, Calado VT, Amorim RL, Neville IS, Andrade AF, Bor-Seng-Shu E, Anghinah R, Teixeira MJ

Neuropsychiatric Disease and Treatment 2014, 10:695-701

Published Date: 2 May 2014

Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia

Beyazyüz M, Albayrak Y, Beyazyüz E, Ünsal C, Göka E

Neuropsychiatric Disease and Treatment 2014, 10:687-693

Published Date: 29 April 2014

Dissociative symptoms reflect levels of tumor necrosis factor alpha in patients with unipolar depression

Bizik G, Bob P, Raboch J, Pavlat J, Uhrova J, Benakova H, Zima T

Neuropsychiatric Disease and Treatment 2014, 10:675-679

Published Date: 25 April 2014

Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study

Seo HJ, Choi YH, Chung YA, Rho W, Chae JH

Neuropsychiatric Disease and Treatment 2014, 10:661-669

Published Date: 17 April 2014

Spatial memory impairments in amnestic mild cognitive impairment in a virtual radial arm maze

Lee JY, Kho S, Yoo HB, Park S, Choi JS, Kwon JS, Cha KR, Jung HY

Neuropsychiatric Disease and Treatment 2014, 10:653-660

Published Date: 17 April 2014

Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population

Yao J, Ding M, Xing JX, Xuan JF, Pang H, Pan YQ, Wang BJ

Neuropsychiatric Disease and Treatment 2014, 10:645-652

Published Date: 17 April 2014

A case report of suicidal behavior related to subclinical hyperthyroidism

Joo SH, Jeong JH, Hong SC

Neuropsychiatric Disease and Treatment 2014, 10:641-643

Published Date: 17 April 2014

Suicidal ideation and the risk of suicide in patients with fibromyalgia: a comparison with non-pain controls and patients suffering from low-back pain

Jimenez-Rodriguez I, Garcia-Leiva JM, Jimenez-Rodriguez BM, Condés-Moreno E, Rico-Villademoros F, Calandre EP

Neuropsychiatric Disease and Treatment 2014, 10:625-630

Published Date: 16 April 2014

Proposed criteria for schizophrenia remission

AlAqeel B

Neuropsychiatric Disease and Treatment 2014, 10:619-623

Published Date: 16 April 2014

Analysis of cardiac autonomic modulation of children with attention deficit hyperactivity disorder

de Carvalho TD, Wajnsztejn R, de Abreu LC, Marques Vanderlei LC, Godoy MF, Adami F, Valenti VE, Monteiro CBM, Leone C, da Cruz Martins KC, Ferreira C

Neuropsychiatric Disease and Treatment 2014, 10:613-618

Published Date: 11 April 2014

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson's disease: a case report

Zhang HW, Wang YY, Liang JC, Förster S, Wu P, Zhao J, Guan YH, Zuo CT

Neuropsychiatric Disease and Treatment 2014, 10:607-611

Published Date: 8 April 2014

Chorea disclosing a polycythemia vera

Liu GD, Chang J, Liu ZJ, Qiang Q, Gu CH, Zhang YY, Wei WS

Neuropsychiatric Disease and Treatment 2014, 10:563-565

Published Date: 5 April 2014

Suicidal behavior among Turkish patients with Parkinson’s disease

Ozdilek B, Gultekin BK

Neuropsychiatric Disease and Treatment 2014, 10:541-545

Published Date: 26 March 2014

A cross-sectional study on perception of stigma by Chinese schizophrenia patients

Ren ZB, Wang HQ, Feng B, Gu CY, Ma YC, Chen H, Li BL, Liu LY

Neuropsychiatric Disease and Treatment 2014, 10:535-540

Published Date: 26 March 2014

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone

Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J

Neuropsychiatric Disease and Treatment 2014, 10:527-533

Published Date: 26 March 2014

Prevalence of depression and its relationship with work characteristics in a sample of public workers

Luca M, Bellia S, Bellia M, Luca A, Calandra C

Neuropsychiatric Disease and Treatment 2014, 10:519-525

Published Date: 25 March 2014

Neuropsychological phenotype of a patient with a de novo 970 kb interstitial deletion in the distal 16p11.2 region

Egger JI, Verhoeven WM, Verbeeck W, de Leeuw N

Neuropsychiatric Disease and Treatment 2014, 10:513-517

Published Date: 25 March 2014

Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report

Miura I, Kono S, Oshima S, Kanno-Nozaki K, Mashiko H, Niwa SI, Yabe H

Neuropsychiatric Disease and Treatment 2014, 10:507-511

Published Date: 25 March 2014

Update on once-daily zonisamide monotherapy in partial seizures

Afra P, Adamolekun B

Neuropsychiatric Disease and Treatment 2014, 10:493-498

Published Date: 19 March 2014

Dissociation in schizophrenia and borderline personality disorder

Pec O, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:487-491

Published Date: 17 March 2014

Improvement of gross motor and cognitive abilities by an exercise training program: three case reports

Alesi M, Battaglia G, Roccella M, Testa D, Palma A, Pepi A

Neuropsychiatric Disease and Treatment 2014, 10:479-485

Published Date: 14 March 2014

When to start aripiprazole therapy in patients with bipolar mania

Sayyaparaju KK, Grunze H, Fountoulakis KN

Neuropsychiatric Disease and Treatment 2014, 10:459-470

Published Date: 13 March 2014

Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders

Kittirattanapaiboon P, Suttajit S, Junsirimongkol B, Likhitsathian S, Srisurapanont M

Neuropsychiatric Disease and Treatment 2014, 10:453-458

Published Date: 13 March 2014

Influence of valproate on the required dose of propofol for anesthesia during electroconvulsive therapy of bipolar affective disorder patients

Hızlı Sayar G, Eryılmaz G, Şemieoğlu S, Özten E, Göğcegöz Gül I

Neuropsychiatric Disease and Treatment 2014, 10:433-438

Published Date: 4 March 2014

Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Tomita T, Furukori H, Kubo K, Nakagami T, Kaneko S

Neuropsychiatric Disease and Treatment 2014, 10:427-432

Published Date: 28 February 2014

Long-term efficacy and safety of iloperidone: an update

Rado JT, Janicak PG

Neuropsychiatric Disease and Treatment 2014, 10:409-415

Published Date: 26 February 2014

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM

Neuropsychiatric Disease and Treatment 2014, 10:391-401

Published Date: 21 February 2014

What’s in the pipeline? Drugs in development for autism spectrum disorder

Sung M, Chin CH, Lim CG, Liew HSA, Lim CS, Kashala E, Weng SJ

Neuropsychiatric Disease and Treatment 2014, 10:371-381

Published Date: 20 February 2014

Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery

Zhang X, Yan X, Gorman J, Hoffman SN, Zhang L, Boscarino JA

Neuropsychiatric Disease and Treatment 2014, 10:361-370

Published Date: 19 February 2014

Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease

Banno K, Nakaaki S, Sato J, Torii K, Narumoto J, Miyata J, Hirono N, Furukawa TA, Mimura M, Akechi T

Neuropsychiatric Disease and Treatment 2014, 10:339-348

Published Date: 17 February 2014

Psychological morbidity, quality of life, and self-rated health in the military personnel

Chou HW, Tzeng WC, Chou YC, Yeh HW, Chang HA, Kao YC, Tzeng NS

Neuropsychiatric Disease and Treatment 2014, 10:329-338

Published Date: 17 February 2014

Olanzapine use in a manic patient during second and third trimester pregnancy

Choi L, Joo SH, Jeong JH

Neuropsychiatric Disease and Treatment 2014, 10:325-328

Published Date: 17 February 2014

Altered baseline brain activity in children with bipolar disorder during mania state: a resting-state study

Lu D, Jiao Q, Zhong Y, Gao W, Xiao Q, Liu X, Lin X, Cheng W, Luo L, Xu C, Lu G, Su L

Neuropsychiatric Disease and Treatment 2014, 10:317-323

Published Date: 17 February 2014

Risk factors associated with postpartum depression in the Saudi population

Alharbi AA, Abdulghani HM

Neuropsychiatric Disease and Treatment 2014, 10:311-316

Published Date: 17 February 2014

Frontotemporal lobar degeneration: current perspectives

Riedl L, Mackenzie IR, Förstl H, Kurz A, Diehl-Schmid J

Neuropsychiatric Disease and Treatment 2014, 10:297-310

Published Date: 13 February 2014

Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear

Masuda T, Inoue T, An Y, Takamura N, Nakagawa S, Kitaichi Y, Koyama T, Kusumi I

Neuropsychiatric Disease and Treatment 2014, 10:289-295

Published Date: 11 February 2014

Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation

Nakayama H, Umeda S, Nibuya M, Terao T, Nisijima K, Nomura S

Neuropsychiatric Disease and Treatment 2014, 10:283-287

Published Date: 11 February 2014

Screening for autism in preterm children with extremely low and very low birth weight

Dudova I, Kasparova M, Markova D, Zemankova J, Beranova S, Urbanek T, Hrdlicka M

Neuropsychiatric Disease and Treatment 2014, 10:277-282

Published Date: 11 February 2014

Tinnitus: clinical experience of the psychosomatic connection

Salviati M, Bersani FS, Terlizzi S, Melcore C, Panico R, Romano GF, Valeriani G, Macrì F, Altissimi G, Mazzei F, Testugini V, Latini L, Delle Chiaie R, Biondi M, Cianfrone G

Neuropsychiatric Disease and Treatment 2014, 10:267-275

Published Date: 10 February 2014

Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate- serotonin interaction

Strzelecki D, Szyburska J, Rabe-Jabłońska J

Neuropsychiatric Disease and Treatment 2014, 10:263-266

Published Date: 4 February 2014

Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder

Leszczyńska-Rodziewicz A, Szczepankiewicz A, Narożna B, Skibińska M, Pawlak J, Dmitrzak-Węglarz M, Hauser J

Neuropsychiatric Disease and Treatment 2014, 10:243-248

Published Date: 3 February 2014

Baseline characteristics of depressive disorders in Thai outpatients: findings from the Thai Study of Affective Disorders

Wongpakaran T, Wongpakaran N, Pinyopornpanish M, Srisutasanavong U, Lueboonthavatchai P, Nivataphand R, Apisiridej N, Petchsuwan D, Saisavoey N, Wannarit K, Ruktrakul R, Srichan T, Satthapisit S, Nakawiro D, Hiranyatheb T, Temboonkiat A, Tubtimtong N, Rakkhajeekul S, Wongtanoi B, Tanchakvaranont S, Bookkamana P

Neuropsychiatric Disease and Treatment 2014, 10:217-223

Published Date: 31 January 2014

Predictors of repeated sick leave in the workplace because of mental disorders

Sado M, Shirahase J, Yoshimura K, Miura Y, Yamamoto K, Tabuchi H, Kato M, Mimura M

Neuropsychiatric Disease and Treatment 2014, 10:193-200

Published Date: 29 January 2014

Design and validation of standardized clinical and functional remission criteria in schizophrenia

Mosolov SN, Potapov AV, Ushakov UV, Shafarenko AA, Kostyukova AB

Neuropsychiatric Disease and Treatment 2014, 10:167-181

Published Date: 28 January 2014

Building a new Rasch-based self-report inventory of depression

Balsamo M, Giampaglia G, Saggino A

Neuropsychiatric Disease and Treatment 2014, 10:153-165

Published Date: 28 January 2014

Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study

Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M

Neuropsychiatric Disease and Treatment 2014, 10:147-151

Published Date: 24 January 2014

Pediatric neurofibromatosis 1 and parental stress: a multicenter study

Esposito M, Marotta R, Roccella M, Gallai B, Parisi L, Lavano SM, Carotenuto M

Neuropsychiatric Disease and Treatment 2014, 10:141-146

Published Date: 22 January 2014

Unmet needs in the management of schizophrenia

Torres-González F, Ibanez-Casas I, Saldivia S, Ballester D, Grandón P, Moreno-Küstner B, Xavier M, Gómez-Beneyto M

Neuropsychiatric Disease and Treatment 2014, 10:97-110

Published Date: 16 January 2014

Measuring quality of sleep and autonomic nervous function in healthy Japanese women

Sato M, Yasuhara Y, Tanioka T, Iwasa Y, Miyake M, Yasui T, Tomotake M, Kobayashi H, Locsin RC

Neuropsychiatric Disease and Treatment 2014, 10:89-96

Published Date: 17 January 2014

Balance deficits and ADHD symptoms in medication-naïve school-aged boys

Konicarova J, Bob P, Raboch J

Neuropsychiatric Disease and Treatment 2014, 10:85-88

Published Date: 15 January 2014

Identifying the affected hemisphere with a multimodal approach in MRI-positive or negative, unilateral or bilateral temporal lobe epilepsy

Zhang J, Liu Q, Mei S, Zhang X, Liu W, Chen H, Xia H, Zhou Z, Wang X, Li Y

Neuropsychiatric Disease and Treatment 2014, 10:71-81

Published Date: 7 January 2014

Relationship between alexithymia and coping strategies in patients with somatoform disorder

Tominaga T, Choi H, Nagoshi Y, Wada Y, Fukui K

Neuropsychiatric Disease and Treatment 2014, 10:55-62

Published Date: 27 December 2013

Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease

Cui G, Yang X, Wang X, Zhang Z, Yue X, Shi H, Shen X

Neuropsychiatric Disease and Treatment 2014, 10:39-46

Published Date: 18 December 2013

Quality of life measurement and outcome in aphasia

Spaccavento S, Craca A, Del Prete M, Falcone R, Colucci A, Di Palma A, Loverre A

Neuropsychiatric Disease and Treatment 2014, 10:27-37

Published Date: 17 December 2013

Total sleep deprivation decreases flow experience and mood status

Kaida K, Niki K

Neuropsychiatric Disease and Treatment 2014, 10:19-25

Published Date: 12 December 2013

Effects of maternal psychotropic drug dosage on birth outcomes

Michielsen LA, van der Heijden FMMA, Janssen PKC, Kuijpers HJH

Neuropsychiatric Disease and Treatment 2014, 10:13-18

Published Date: 10 December 2013